Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00952653 · ClinicalTrials.gov registry record · Phase 4

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

A Phase 4 study of Major Depressive Disorder, sponsored by Pfizer.

Completed
Registry status
Phase 4
Development phase
28
Enrollment target
1
Study location

NCT00952653 is a Phase 4 study of Major Depressive Disorder that has completed, run by Pfizer. The registered enrollment target is 28 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00952653, a Phase 4 study of Major Depressive Disorder, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 4
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to evaluate the effect of desvenlafaxine administered as DVS SR on the pharmacokinetics of midazolam in healthy male and female subjects. The amount of drug in the body and the effect of the drug will also be evaluated.

Conditions Studied

Major Depressive Disorder

Interventions

  • DRUG Midazolam
  • DRUG Desvenlafaxine Succinate Sustained Release

Study Locations (1)

Connecticut

  • Pfizer Investigational Site - New Haven

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2010-06
Est. Completion 2010-08
Phase Phase 4

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00952653

The ClinicalTrials.gov registry entry for NCT00952653 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Midazolam is the first listed.

NCT00952653 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00952653 about?

NCT00952653 is a clinical study titled "Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam". The main purpose of this study is to evaluate the effect of desvenlafaxine administered as DVS SR on the pharmacokinetics of midazolam in healthy male and female subjects. The amount of drug in the body and the effect of the drug will also be evaluated.

What is the current status of trial NCT00952653?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2010-06. Estimated completion is 2010-08.

What conditions does trial NCT00952653 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT00952653?

The interventions under investigation include: Midazolam (DRUG), Desvenlafaxine Succinate Sustained Release (DRUG).

Who is sponsoring clinical trial NCT00952653?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00952653 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Major Depressive Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.